Jim Cramer has praised Cardinal Health's intelligence and ability to do more than just distribution. They have reported successful Q2 fiscal year 2025 results and raised their outlook for the rest of the fiscal year. Their stock has been performing well even as the market falls. With majority ownership being institutional, they have strong backing. Strategic additions have been made to their portfolio while their board of directors approves of a quarterly dividend. Over the past five years, investments in the firm have grown by 196%. Several independent directors with tech and healthcare expertise have been welcomed to the board. They have also been selected by Telix for a U.S. launch of Gozellix Imaging Agent. Furthermore, they have announced plans to open a new distribution center in Fort Worth, Texas and have achieved additions including a GI alliance and two deals worth $3.9 bln expansion. Prospects look promising for the firm as they acquire Integrated Oncology Network and their stock continues to be undervalued. Their new high and positive Q2 earning reports make this firm a top value & momentum stock in the long run.
Cardinal Health CAH News Analytics from Wed, 14 Aug 2024 07:00:00 GMT to Fri, 18 Apr 2025 15:44:18 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor 4
